Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...
As certain weight-loss drugs have become increasingly popular, scammers are taking notice and coming out of the woodwork to ...
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Kingston: One of the most popular new year's resolutions is making a commitment to healthier eating. Whether that's eating ...
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
There is a risk too many people are being diagnosed as obese when "a more accurate" and "nuanced" definition is needed, a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback